Investor Presentaiton slide image

Investor Presentaiton

Volatile income and expense items Volatile items (in € mln) 2Q2022 3Q2022 4Q2022 1Q2023 2Q2023 WB/FM - valuation adjustments 90 -15 -2 -10 33 Capital gains/losses 8 -3 0 15 -0 Hedge ineffectiveness¹) -31 -431 -71 35 -46 Other items income²) -155 -218 -319 -69 -6 Total volatile items - income -89 -668 -392 -29 -21 Incidental items - expenses³) -159 -85 -82 -4 -6 Total volatile items -247 -753 -473 -34 -27 1) 3Q2022: includes €-288 mln to unwind a macro fair value hedge of deposits in Belgium 2) 2Q2022: €76 mln TLTRO III benefit and €-231 mln due to hyperinflation accounting in Türkiye 3) 3Q2022: €71 mln TLTRO III benefit, €-343 mln impact Polish mortgage moratorium, €+100 mln from the transfer of our investment business in France, €-31 mln hyperinflation impact and €-15 mln impairment on our equity stake in TTB 4Q2022: €-315 mln net TLTRO III impact, €+14 mln from the transfer of our investment business in France and €-17 million hyperinflation impact 1Q2023: €-69 million hyperinflation impact 2Q2023: €-6 million hyperinflation impact 2Q2022: €97 mln restructuring costs in RB Belgium and €18 mln in Retail OC&GM and €43 mln hyperinflation impact (o.w. €32 mln impairment) 302022: €75 mln for adding interest-on-interest to compensation for certain Dutch consumer credit products and €10 mln hyperinflation impact 4Q2022: €43 mln restructuring costs, €30 mln energy allowances for employees and €9 mln hyperinflation impact 1Q2023: €4 mln hyperinflation impact 2Q2023: €6 mln hyperinflation impact 18
View entire presentation